India’s first compulsory licence last year sparked worries that it would be the first of many and accusations that the country was engaging in discriminatory practices against international rights ...

Indian generic drug maker Natco has filed a compulsory licence application for the patent covering German pharma company Bayer’s anti-cancer drug Nexavar This is the first application for a compulsory ...

The licence was granted to Natco Pharma, a generic drug company, for sorafenib tosylate, a life-extending drug developed, patented and launched by Bayer Corporation. This drug is sold under the trade ...

New Delhi: The India-UK free trade agreement does not restrict India's use of compulsory licensing (CL) in any form, Parliament was informed on Friday.CL is a critical tool for accessing life-saving ...

BioWorld - Thursday, August 22, 2024 See today's BioWorld Asia Home » India's first compulsory license stands; Bayer loses Nexavar appeal X Upgrade your daily dose of biopharma and medtech news ...